How do we get ATMPs over the line in Europe?

08.06.2023
"Ready for market: How do we get ATMPs over the line in Europe?" is the topic of a webinar to be held on June 8.
Online, 08.06.2023

Prof. Matthias P. Schönermark M.D., Ph.D., managing director of SKC, will discuss the challenges of developing and commercializing ATMPs in Europe with Sven Kili (Antion Biosciences), Miguel Forte (ISCT) and Katrien Reynders (HollandBio). Key issues addressed are:

  • What's holding back development in Europe?
  • What infrastructure do we need for ATMPs in Europe?
  • How do we boost approval, market and patient access?

Here you can view the recording of the webinar.

Get in touch

Ihr Ansprechpartner Prof. Matthias P. Schönermark, M.D., Ph.D.
Prof. Matthias P. Schönermark, M.D., Ph.D.
Founder and Managing Director
Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18

Whitepaper


Successful market access for gene therapies - Strategic challenges and possible solutions
to the top
powered by webEdition CMS